February 14, 2025
Board of Directors
Review and approval of KPIs* for Q4 2024
————————————————————————————-
April 30, 2025
Board of Directors
Approval of the annual financial statements and the consolidated group financial statements as of December 31, 2024
————————————————————————————-
May 14, 2025
Board of Directors
Review and approval of KPIs* for Q1 2025
————————————————————————————-
May 29, 2025
Ordinary Shareholders’ Meeting
Approval of the financial statements as of December 31, 2024
———————————————————————————
August 1, 2025
Board of Directors
Review and approval of KPIs* for Q2 2025
————————————————————————————-
September 19, 2025
Board of Directors
Approval of the consolidated half-year financial report as of June 30, 2025, voluntarily subjected to limited audit
————————————————————————————-
November 14, 2025
Board of Directors
Review and approval of KPIs* for Q3 2025
————————————————————————————-
February 13, 2026
Board of Directors
Review and approval of KPIs* for Q4 2025
*The monitored KPIs will be Consolidated Net Sales, Total Consolidated Revenues, Consolidated Net Financial Position, Consolidated Order Backlog, and Consolidated EBITDA – consolidated management data not subject to audit